Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1802 1
1887 1
1946 1
1949 2
1950 4
1954 1
1955 2
1956 2
1957 1
1958 1
1959 2
1960 4
1961 6
1962 12
1963 1
1965 2
1966 1
1967 3
1968 11
1969 10
1970 11
1971 11
1972 12
1973 17
1974 10
1975 9
1976 9
1977 13
1978 15
1979 7
1980 9
1981 6
1982 16
1983 10
1984 16
1985 7
1986 16
1987 17
1988 11
1989 17
1990 19
1991 31
1992 11
1993 27
1994 27
1995 22
1996 25
1997 15
1998 42
1999 28
2000 27
2001 33
2002 51
2003 51
2004 41
2005 47
2006 47
2007 53
2008 72
2009 90
2010 112
2011 137
2012 124
2013 112
2014 144
2015 145
2016 150
2017 155
2018 149
2019 164
2020 210
2021 221
2022 197
2023 163
2024 100

Text availability

Article attribute

Article type

Publication date

Search Results

2,996 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Garvey WT, et al. Among authors: le roux cw. Lancet. 2023 Aug 19;402(10402):613-626. doi: 10.1016/S0140-6736(23)01200-X. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385275 Clinical Trial.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. Among authors: le roux cw. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
Toxin-Antitoxin Systems as Phage Defense Elements.
LeRoux M, Laub MT. LeRoux M, et al. Annu Rev Microbiol. 2022 Sep 8;76:21-43. doi: 10.1146/annurev-micro-020722-013730. Epub 2022 Apr 8. Annu Rev Microbiol. 2022. PMID: 35395167 Review.
Mechanisms of Weight Loss After Obesity Surgery.
Akalestou E, Miras AD, Rutter GA, le Roux CW. Akalestou E, et al. Among authors: le roux cw. Endocr Rev. 2022 Jan 12;43(1):19-34. doi: 10.1210/endrev/bnab022. Endocr Rev. 2022. PMID: 34363458 Free PMC article. Review.
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes.
Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK, Rothberg AE, le Roux CW, Rubino F, Schauer P, Taylor R, Twenefour D. Riddle MC, et al. Among authors: le roux cw. Diabetes Care. 2021 Aug 30;44(10):2438-44. doi: 10.2337/dci21-0034. Online ahead of print. Diabetes Care. 2021. PMID: 34462270 Free PMC article. Review.
Phage-host coevolution in natural populations.
Piel D, Bruto M, Labreuche Y, Blanquart F, Goudenège D, Barcia-Cruz R, Chenivesse S, Le Panse S, James A, Dubert J, Petton B, Lieberman E, Wegner KM, Hussain FA, Kauffman KM, Polz MF, Bikard D, Gandon S, Rocha EPC, Le Roux F. Piel D, et al. Among authors: le roux f. Nat Microbiol. 2022 Jul;7(7):1075-1086. doi: 10.1038/s41564-022-01157-1. Epub 2022 Jun 27. Nat Microbiol. 2022. PMID: 35760840 Free article.
New therapies for obesity.
Papamargaritis D, le Roux CW, Holst JJ, Davies MJ. Papamargaritis D, et al. Among authors: le roux cw. Cardiovasc Res. 2024 Feb 17;119(18):2825-2842. doi: 10.1093/cvr/cvac176. Cardiovasc Res. 2024. PMID: 36448672 Free PMC article.
Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland.
Breen C, O'Connell J, Geoghegan J, O'Shea D, Birney S, Tully L, Gaynor K, O'Kelly M, O'Malley G, O'Donovan C, Lyons O, Flynn M, Allen S, Arthurs N, Browne S, Byrne M, Callaghan S, Collins C, Courtney A, Crotty M, Donohue C, Donovan C, Dunlevy C, Duggan D, Fearon N, Finucane F, Fitzgerald I, Foy S, Garvey J, Gibson I, Glynn L, Gregg E, Griffin A, Harrington JM, Heary C, Heneghan H, Hogan A, Hynes M, Kearney C, Kelly D, Neff K, le Roux CW, Manning S, McAuliffe F, Moore S, Moran N, Murphy M, Murrin C, O'Brien SM, O'Donnell C, O'Dwyer S, O'Grada C, O'Malley E, O'Reilly O, O'Reilly S, Porter O, Roche HM, Rhynehart A, Ryan L, Seery S, Soare C, Shaamile F, Walsh A, Woods C, Woods C, Yoder R. Breen C, et al. Among authors: le roux cw. Obes Facts. 2022;15(6):736-752. doi: 10.1159/000527131. Epub 2022 Oct 24. Obes Facts. 2022. PMID: 36279848 Free PMC article. Review.
2,996 results